JP2023021979A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023021979A5 JP2023021979A5 JP2022171607A JP2022171607A JP2023021979A5 JP 2023021979 A5 JP2023021979 A5 JP 2023021979A5 JP 2022171607 A JP2022171607 A JP 2022171607A JP 2022171607 A JP2022171607 A JP 2022171607A JP 2023021979 A5 JP2023021979 A5 JP 2023021979A5
- Authority
- JP
- Japan
- Prior art keywords
- application
- xml
- entirety
- hereby incorporated
- sequence listing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662289671P | 2016-02-01 | 2016-02-01 | |
| US62/289,671 | 2016-02-01 | ||
| JP2018559673A JP2019511562A (ja) | 2016-02-01 | 2017-02-01 | Ｒｎａ媒介疾患を処置する化合物および方法 |
| JP2021087002A JP7167248B2 (ja) | 2016-02-01 | 2021-05-24 | Ｒｎａ媒介疾患を処置する化合物および方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021087002A Division JP7167248B2 (ja) | 2016-02-01 | 2021-05-24 | Ｒｎａ媒介疾患を処置する化合物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023021979A JP2023021979A (ja) | 2023-02-14 |
| JP2023021979A5 true JP2023021979A5 (https=) | 2023-04-11 |
Family
ID=59499945
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018559673A Pending JP2019511562A (ja) | 2016-02-01 | 2017-02-01 | Ｒｎａ媒介疾患を処置する化合物および方法 |
| JP2021087002A Active JP7167248B2 (ja) | 2016-02-01 | 2021-05-24 | Ｒｎａ媒介疾患を処置する化合物および方法 |
| JP2022171607A Pending JP2023021979A (ja) | 2016-02-01 | 2022-10-26 | Ｒｎａ媒介疾患を処置する化合物および方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018559673A Pending JP2019511562A (ja) | 2016-02-01 | 2017-02-01 | Ｒｎａ媒介疾患を処置する化合物および方法 |
| JP2021087002A Active JP7167248B2 (ja) | 2016-02-01 | 2021-05-24 | Ｒｎａ媒介疾患を処置する化合物および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20200115372A1 (https=) |
| EP (1) | EP3411080A4 (https=) |
| JP (3) | JP2019511562A (https=) |
| CN (2) | CN108778345B (https=) |
| AU (1) | AU2017215201B2 (https=) |
| CA (1) | CA3012700A1 (https=) |
| IL (2) | IL260859B (https=) |
| MX (1) | MX2018009325A (https=) |
| RU (1) | RU2018127537A (https=) |
| SG (1) | SG11201806544XA (https=) |
| WO (1) | WO2017136450A2 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201811643TA (en) * | 2016-07-01 | 2019-01-30 | Arrakis Therapeutics Inc | Compounds and methods for modulating rna function |
| WO2018151810A1 (en) | 2017-02-17 | 2018-08-23 | The Scripps Research Institute | Defining rna-small molecule affinity landscapes enables design of a small molecular inhibitor of an oncogenic non-coding rna |
| JP7312749B2 (ja) | 2017-08-04 | 2023-07-21 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングをモジュレートする方法および組成物 |
| RU2020112854A (ru) | 2017-11-30 | 2021-12-30 | Арракис Терапьютикс, Инк. | Фотозонды, связывающие нуклеиновые кислоты, и способы их применения |
| WO2019236644A1 (en) * | 2018-06-05 | 2019-12-12 | Arrakis Therapeutics, Inc. | Encoded libraries and methods of use for screening nucleic acid targets |
| CN109928933B (zh) * | 2019-01-10 | 2021-02-26 | 安徽昊帆生物有限公司 | 2-氯-5-醛基嘧啶及其制备方法 |
| JP7551629B2 (ja) | 2019-02-05 | 2024-09-17 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングを調節するための方法および組成物 |
| WO2020163405A1 (en) | 2019-02-05 | 2020-08-13 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
| JP7603595B2 (ja) | 2019-02-06 | 2024-12-20 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングを調節するための方法および組成物 |
| JP7603594B2 (ja) | 2019-02-06 | 2024-12-20 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングを調節するための方法および組成物 |
| US20220073910A1 (en) * | 2019-02-12 | 2022-03-10 | The Scripps Research Institute | A Cross-Linking Approach to Map Small Molecule-RNA Binding Sites in Cells |
| WO2020264572A1 (en) * | 2019-06-27 | 2020-12-30 | The Scripps Research Institute | Fragment-based screening to identify small molecules that selectively bind rna |
| TW202131920A (zh) * | 2019-11-01 | 2021-09-01 | 瑞士商諾華公司 | 剪接調節子用於減慢杭丁頓氏舞蹈症進展的治療之用途 |
| GB2591088B (en) * | 2020-01-08 | 2024-07-03 | Adv Med Solutions Ltd | Antimicrobial fibres |
| US20250114465A1 (en) * | 2021-10-28 | 2025-04-10 | Arrakis Therapeutics, Inc. | Rna degraders and uses thereof |
| CN114373522B (zh) * | 2022-01-13 | 2024-09-27 | 腾讯科技（深圳）有限公司 | 分子生成模型的训练方法、装置、设备及存储介质 |
| EP4463188A4 (en) * | 2022-01-14 | 2025-10-22 | Univ Leland Stanford Junior | CHEMICALLY REVERSIBLE 2´-OH ACYLATION PROTECTS RNA FROM HYDROLYTIC AND ENZYMATIC DEGRADATION |
| WO2024112918A1 (en) * | 2022-11-23 | 2024-05-30 | Arrakis Therapeutics, Inc. | Rna degraders and uses thereof |
| CN115850907B (zh) * | 2022-12-29 | 2024-12-17 | 福建泓光半导体材料有限公司 | 一种酚醛树脂组合物及其制备方法和应用以及固化浮雕图案的制备方法 |
| CN119320798A (zh) * | 2023-07-17 | 2025-01-17 | 中国科学院上海营养与健康研究所 | 一种可用于筛选针对rna重复序列药物的报告系统 |
| WO2025024573A1 (en) * | 2023-07-24 | 2025-01-30 | Arrakis Therapeutics, Inc. | Ccr4-not binding rna degraders |
| WO2025137537A1 (en) * | 2023-12-22 | 2025-06-26 | Arrakis Therapeutics, Inc. | Compositions and methods for treating myc-mediated diseases |
| WO2025184391A1 (en) * | 2024-02-27 | 2025-09-04 | Arrakis Therapeutics, Inc. | Covalent inhibitors and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6354363A (ja) * | 1986-08-26 | 1988-03-08 | Ss Pharmaceut Co Ltd | キノリン誘導体 |
| US5514786A (en) * | 1990-01-11 | 1996-05-07 | Isis Pharmaceuticals, Inc. | Compositions for inhibiting RNA activity |
| US7074801B1 (en) * | 2001-04-26 | 2006-07-11 | Eisai Co., Ltd. | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| US9150612B2 (en) * | 2007-02-23 | 2015-10-06 | The Research Foundation Of State University Of New York | RNA targeting compounds and methods for making and using same |
| SI2384318T1 (en) * | 2008-12-31 | 2018-03-30 | Ardelyx, Inc. | MEASURES AND PROCEDURES FOR THE INHIBITION OF ANTIPORT INHIBITED BY NHE IN THE TREATMENT OF DISEASES RELATED TO STRENGTH OF FLAMMABILITY OR TRADEMARITY WITH SOLO, AND THE EMISSION OF GASTROINTESTINAL TREATMENT |
| CA2877985C (en) * | 2012-07-10 | 2020-10-27 | Baseclick Gmbh | Anandamide-modified nucleic acid molecules |
| JP2015527322A (ja) * | 2012-07-10 | 2015-09-17 | ジョージア ステイト ユニバーシティ リサーチ ファンデーション， インコーポレイテッド | アントラキノン類似体ならびにその作製方法および使用方法 |
| US8729263B2 (en) * | 2012-08-13 | 2014-05-20 | Novartis Ag | 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions |
| IL316808A (en) * | 2014-08-20 | 2025-01-01 | Alnylam Pharmaceuticals Inc | Modified double-stranded RNA materials and their uses |
| WO2016069922A1 (en) * | 2014-10-29 | 2016-05-06 | Biotium, Inc. | Nucleic acid modifying agents and uses thereof |
-
2017
- 2017-02-01 MX MX2018009325A patent/MX2018009325A/es unknown
- 2017-02-01 CN CN201780018534.9A patent/CN108778345B/zh active Active
- 2017-02-01 SG SG11201806544XA patent/SG11201806544XA/en unknown
- 2017-02-01 AU AU2017215201A patent/AU2017215201B2/en active Active
- 2017-02-01 RU RU2018127537A patent/RU2018127537A/ru unknown
- 2017-02-01 WO PCT/US2017/016065 patent/WO2017136450A2/en not_active Ceased
- 2017-02-01 US US16/074,232 patent/US20200115372A1/en not_active Abandoned
- 2017-02-01 JP JP2018559673A patent/JP2019511562A/ja active Pending
- 2017-02-01 CN CN202211442068.6A patent/CN115721729A/zh active Pending
- 2017-02-01 CA CA3012700A patent/CA3012700A1/en active Pending
- 2017-02-01 EP EP17748078.7A patent/EP3411080A4/en not_active Withdrawn
-
2018
- 2018-07-30 IL IL260859A patent/IL260859B/en active IP Right Grant
-
2021
- 2021-05-24 JP JP2021087002A patent/JP7167248B2/ja active Active
- 2021-06-08 IL IL283799A patent/IL283799B/en unknown
- 2021-12-17 US US17/644,986 patent/US20220281860A1/en not_active Abandoned
-
2022
- 2022-10-26 JP JP2022171607A patent/JP2023021979A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023021979A5 (https=) | ||
| JP2019502892A5 (https=) | ||
| JP2021524958A5 (https=) | ||
| CN112004801A (zh) | 一种c-MET 抑制剂的晶型及其盐型和制备方法 | |
| JP2012501504A5 (https=) | ||
| JPWO2019229543A5 (https=) | ||
| JP2013517798A5 (https=) | ||
| JP2019514354A5 (https=) | ||
| JP2022518511A5 (https=) | ||
| JP2018520447A5 (https=) | ||
| CN111655682A (zh) | 一种高活性sting蛋白激动剂化合物 | |
| JP2015512691A5 (https=) | ||
| MX2009012950A (es) | ANTICUERPOS HUMANIZADOS CONTRA EL GLOBULOMERO Aß (20-42) Y SUS USOS. | |
| JP2012504317A5 (https=) | ||
| JP2020530380A5 (https=) | ||
| JP2011515029A5 (https=) | ||
| WO2008001224A3 (en) | Polypeptides from neisseria meningitidis | |
| EP4321165A3 (en) | Method for diagnosis of alzheimer's disease and frontotemporal lobar degeneration, diagnostic agent, therapeutic agent, and screening method for said agents | |
| JP2014533241A5 (https=) | ||
| CN109715660A (zh) | 一种能够特异性地结合il-17a的抗体及其功能片段 | |
| JP2014508098A5 (https=) | ||
| CN111836665A (zh) | 放射治疗系统及其验证装置、验证方法 | |
| JP2021500874A5 (https=) | ||
| JP2014518965A5 (https=) | ||
| JP2016527801A5 (https=) |